Physician profile
M Bruce Christopherson
NPI 1023029675
$3,401.34
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,597 · 2020: $450 · 2021: $537 · 2022: $780 · 2023: $36.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,034.10 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Novo Nordisk INC | $463.62 | 2019-2022 | |
| Amgen INC. | $257.48 | 2019-2022 | |
| Therapeuticsmd, INC. | $226.33 | 2019-2022 | |
| Pfizer INC. | $223.20 | 2019-2022 | |
| Lupin INC. | $151.19 | 2019 | |
| Duchesnay USA Incorporated | $147.19 | 2019 | |
| Astellas Pharma US INC | $132.41 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $106.10 | 2022 | |
| Allergan, INC. | $75.97 | 2019-2020 | |
| Hologic Sales and Service, LLC | $62.23 | 2019-2022 | |
| Exeltis, USA INC. | $60.91 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.65 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $52.54 | 2020-2021 | |
| Ethicon US, LLC | $34.33 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $33.18 | 2021-2022 | |
| Myovant Sciences INC. | $26.94 | 2021 | |
| Ascend Therapeutics US, LLC | $26.30 | 2022 | |
| Medtronic, INC. | $25.44 | 2022 | |
| Minerva Surgical, INC | $24.86 | 2019 | |
| Covidien LP | $21.71 | 2019 | |
| Amag Pharmaceuticals, INC. | $20.63 | 2020 | |
| Zyla Life Sciences, INC. | $20.42 | 2020 | |
| Organon LLC | $19.71 | 2022 | |
| Millicent US INC | $18.53 | 2019 | |
| Mylan Pharmaceuticals INC. | $18.27 | 2021 | |
| Renovia INC | $17.07 | 2019 | |
| Scynexis, INC. | $16.19 | 2022 | |
| Vertical Pharmaceuticals, LLC | $13.19 | 2019 | |
| Acessa Health INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw M Bruce Christopherson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.